Lumefantrine Solid Dispersion Formulation
Showing 1 - 25 of >10,000
Acute Uncomplicated Plasmodium Falciparum Malaria Trial in Worldwide (KAF156, Coartem, Lumefantrine Solid Dispersion
Completed
- Acute Uncomplicated Plasmodium Falciparum Malaria
- KAF156
- +2 more
-
Nanoro, Burkina Faso
- +10 more
Dec 21, 2021
Pharmacokinetics, Drug Interactions Trial in Dilworth (Dasatinib ASD, Omeprazole 40 MG)
Completed
- Pharmacokinetics
- Drug Interactions
- Dasatinib ASD
- Omeprazole 40 MG
-
Dilworth, MinnesotaAXIS Clinicals
Jun 21, 2022
Inflammatory Disease, Periodontal Diseases Trial (Debridement, Group I, Group II)
Not yet recruiting
- Inflammatory Disease
- Periodontal Diseases
- Debridement
- +3 more
- (no location specified)
Sep 15, 2022
Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5
Recruiting
- Plasmodium Falciparum Malaria
- artemether:lumefantrine (2.5 mg:30 mg)
-
Nanoro, Burkina Faso
- +5 more
Nov 28, 2022
Spinal Fusion Trial in Bologna (Vertebral bone marrow clot)
Active, not recruiting
- Spinal Fusion
- Vertebral bone marrow clot
-
Bologna, BO, ItalyIstituto Ortopedico Rizzoli
Jun 27, 2023
Malaria Trial (Ganaplacide, Lumefantrine, Efavirenz)
Completed
- Malaria
- Ganaplacide
- +2 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Jan 11, 2023
Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide
Recruiting
- Uterine Cervical Neoplasms
- +10 more
- Pembrolizumab/Vibostolimab Co-Formulation
- +11 more
-
Anchorage, Alaska
- +65 more
Jan 27, 2023
Malaria Trial in Belfast (Ganaplacide, Lumefantrine, Itraconazole)
Completed
- Malaria
- Ganaplacide
- +2 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Oct 27, 2022
Pigment Dispersion Syndrome, Pigmentary Glaucoma Trial in Fayoum (Argon Laser Iridoplasty)
Recruiting
- Pigment Dispersion Syndrome
- Pigmentary Glaucoma
- Argon Laser Iridoplasty
-
Fayoum, EgyptFayoum University Hospitals
Jul 23, 2022
Malaria Trial in Worldwide (pyronaridine artesunate, arthemeter lumefantrine)
Completed
- Malaria
- pyronaridine artesunate
- arthemeter lumefantrine
-
Ouagadougou, Burkina Faso
- +7 more
Oct 22, 2021
Malaria, Falciparum Trial in Cambodia, Vietnam (ACT, TACT)
Completed
- Malaria, Falciparum
-
Siem Pang, Stung Treng, Cambodia
- +3 more
Mar 17, 2022
Soft Tissue Infections, Gingival Recession Trial in Assiut (hydroxylate flavones solid dispersion application, Placebo)
Not yet recruiting
- Soft Tissue Infections
- Gingival Recession
- hydroxylate flavones solid dispersion application
- Placebo
-
Assiut, EgyptAssiut University
Apr 13, 2023
Dispersion of Shoulder Helical Axes Before and After Physical
Not yet recruiting
- Shoulder Instability
- (no location specified)
Oct 3, 2022
Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)
Not yet recruiting
- Melanoma
- +16 more
-
Darlinghurst, New South Wales, Australia
- +3 more
May 12, 2023
Advanced Solid Tumor Trial in Taichung, Taipei (TRX-920 Oral Gel (10 mg and 30 mg))
Recruiting
- Advanced Solid Tumor
- TRX-920 Oral Gel (10 mg and 30 mg)
-
Taichung, Taiwan
- +1 more
Nov 20, 2023
Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)
Recruiting
- Advanced Solid Malignancies
- Ami-LC-MD
- +4 more
-
West Hollywood, California
- +13 more
Jan 31, 2023
Healthy Participants Trial in Dallas (AMG 510)
Completed
- Healthy Participants
- AMG 510
-
Dallas, TexasCovance Clinical Research Unit, Inc 1341 W Mockingbird Ln, Ste 2
Oct 5, 2022
Healthy Trial in Singapore (LY3871801)
Completed
- Healthy
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Mar 17, 2022
Healthy Volunteers Trial in Nottingham (Oral solution, [14C]BMS-986177 Solution for Infusion, BMS-986177 Spray-dried Dispersion
Completed
- Healthy Volunteers
- Oral solution
- +2 more
-
Nottingham, United KingdomLocal Institution
Nov 11, 2021
Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)
Recruiting
- Solid Tumor, Adult
- HF1K16 /Arm 45 mg/m2
- +3 more
-
Shanghai, Shanghai, China
- +2 more
May 23, 2022